Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
Association of Amount of Weight Lost After Bariatric Surgery with Intracranial Pressure in Women with Idiopathic Intracranial Hypertension
Neurol 99:e1090-e1099, Mollan, S.P.,et al, 2022
Acupuncture for Patients with Chronic Tension-Type Headache
Neurol 99:e1560-e1569, Zheng, H.,et al, 2022
A Rare Treatable and Under Recognized Cause of Recurrent Convexity Subarachnoid Hemorrhage:Lupus anticoagulant Hypoprothombinemia Syndrome
Ann Indian Acad Neurol 24:986-989, Jain, S.,et al, 2021
An Underrecognized Etiology of New Daily Persistent Headache
Neurol 94:e114-e120, Duvall, J.R.,et al, 2020
Immunocompetent Patient with Multiple Cranial Nerve Palsies, Ataxia, and Cognitive Decline
Neurol 94:e225-e229, Nigam, M.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Dural Defect Repair as Treatment for Refractory Headache From Cerebrospinal Fluid Leak
Neurol 95:e2831-e2833, Chan,T.L.H., et al, 2020
A Teenager with Persistent Headache
Neurol 92:e1526-e1531, Hu, Y.,et al, 2019
Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019
A Headache of a Diagnosis
NEJM 379:475-479, Stern,R.M.,et al, 2018
Preventive Migraine Drug Approved
JAMA 320:1746, , 2018
Neuro-Sweet Disease Presenting as Ischemic Stroke and Aseptic Meningitis
Neurol 91:e2197-e2199, Das, A.S.,et al, 2018
Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018
Neurological Manifestations Among US Government Personnel Reporting Directional Audible and Sensory Phenomena in Havana, Cuba
JAMA 319:1125-1133, 1098, 1079, Swanson, R.L.,et al, 2018
CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017
Clinicopathologic Conference Cryptococcal Meningitis in a Patient with Chronic HIV Infection
NEJM 376:1065-1071, Case 8-2017, 2017
Superficial Siderosis Presenting as Chronic Migraine: Rare Presentation of a Rare Disease
Ann Indian Acad Neurol 20:73-74, Chowdhury, D.,et al, 2017
A 34-Year-Old Man with Headache, Diploplia, and Hemiparesis
Neurol 86:e28, Lincoln, M.R.,et al, 2016
Ventral Tegmental Area Deep Brain Stimulation for Refractory Chronic Cluster Headache
Neurol 86:1676-1682, Akram, H.,et al, 2016
Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache
Neurol 86:1818-1826, Simpson, D.M.,et al, 2016
Reversible Cerebral Vasoconstriction Syndromes and Primary Angiitis of the Central Nervous System: Clinical, Imaging, and Angiographic Comparison
Ann Neurol 79:882-894, Singhal, A.B.,et al, 2016
Chronic Migraine Headache Prevention with Noninvasive Vagus Nerve Stimulation
Neurol 87:529-538, Silberstein, S.D.,et al, 2016
Mouse Infestation Likely Source of Lymphocytic Choriomeningitis in Teen
MMWR 65:248-249, Rostad, C.A. & Pickering, L.K., 2016
The Acquired Metabolic Disorders of the Nervous System, Carbon Monoxide Poisoning
Adams & Victors Principles of Neurology Chp 40, pg 1138, Ropper, A.H.,et al, 2014
Polycythemia Vera Presenting with Ischemic Strokes in Multiple Arterial Territories
Neurol 82:e168-e170, Billakota, S. & Husseini, N.E., 2014
Chronic Migraine
BMJ 348:g141b, Schwedt, T.J., 2014
Aspergillus Meningitis: A Rare Clinical Manifestation of Central Nervous System Aspergillosis
J Infect 66:218-238, Antinori, S.,et al, 2013
Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults
JAMA 307:1736-1745, Jackson,J.L.,et al, 2012
Multimodal Imaging of Reversible Cerebral Vasoconstriction Syndrome: A Series of 6 Cases
AJNR 33:1403-1410, Marder, C.P.,et al, 2012
A 48-year old woman with Recurrent Headache, Transient Neurologic Symptoms, and CSF Pleocytosis
Neurol 79e59-e62, Kerasnoudis, A.,et al, 2012
Clinicopathologic Conference, Susacs Syndrome (retinocochleocerebral vasculopathy)
NEJM 365:549-559, Case 24-2011, 2011
Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
OnabotulinumtoxinA Improves Quality of Life and Reduces Impact of Chronic Migraine
Neurol 77:1465-1472, Lipton, R.B.,et al, 2011
Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011
Lateral Sinus Thrombosis: Complication of Minor Head Injury
Int J Pediatr Otorhinolaryngol 73:629-635, Nehme, J.,et al, 2009
Facial Pain
The Neurologist 15:171-177, Graff-Radford,S.B., 2009
The Severity of Dependence Scale Detects People with Medication Overuse: The Akershus Study of Chronic Headache
JNNP 80:784-789,704, Grande,R.B.,et al, 2009
Chronic Daily Headache in Adolescents: An 8-Year Follow-Up Study
Neurol 73:416-422,412, Wang,S.-J.,et al, 2009
Case 38-2009: A 16-Year-Old Boy with Paroxysmal Headaches and Visual Changes
NEJM 361:2367-2378, Brass,S.,et al, 2009
Botulinum Toxin Type A for the Treatment of Headache: Why We Say Yes
Arch Neurol 65:146-149,151, Ashkenazi,A. &Silberstein,S., 2008
Headache Therapy With Botulinum Toxin: Form Over Substance
Arch Neurol 65:149-151,151, Pakalnis,A. &Couch,J., 2008
Call-Fleming Syndrome Associated with Subarachnoid Haemorrhage: Three New Cases
JNNP 79:602-605, Moustafa,R.R.,et al, 2008
Parenteral Dexamethasone for Acute Severe Migraine Headache: Meta-Analysis of Randomised Controlled Trials for Preventing Recurrence
BMJ 336:1359-1361,1336, Colman,I.,et al., 2008
Clinical Course in Migraine: Conceptualizing Migraine Transformation
Neurol 71:848-855, Bigal,M.E. &Lipton,R.B., 2008
Clinicopath Conf, Giant-Cell Arteritis
NEJM 359:2267-2278, Case 36-2008, 2008
Clinicopath Conf, Giant-Cell Arteritis
NEJM 359:2267-2278,1153, Case 36-2008, 2008
Prednisolone Does Not Reduce Withdrawal Headache
Neurol 69:26-31, Boe,M.G., et al, 2007
The Clinical and Radiological Spectrum of Reversible Cerebral Vasoconstriction Syndrome. A Prospective Series of 67 Patients
Brain 130:3091-3101, Ducros, A.,et al, 2007